MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Myopia control spectaclesDevice: MyopiaX
- First Posted Date
- 2021-07-19
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Dopavision GmbH
- Target Recruit Count
- 124
- Registration Number
- NCT04967287
- Locations
- 🇩🇪
MVZ Makula-Netzhaut-Zentrum Breyer Kaymak Klabe, Düsseldorf, Germany
🇩🇪Suedblick GmbH, Augsburg, Germany
🇳🇱Erasmus University Medical Center, Rotterdam, Netherlands
© Copyright 2025. All Rights Reserved by MedPath